Forbion Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 36

Professionals

  • Investments
  • 256

  • Portfolio
  • 68

  • Exits
  • 109

Exits

Forbion General Information

Company Description

Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands. The firm prefers to invest in biotech, human health, and planetary health sectors.

Business Details

Website
www.forbion.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Trade Association
Dutch Venture Capital Association (NVP)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
+31 035

Forbion Investments & Acquisitions (256)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
VectorY Therapeutics 11-Nov-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 1
OMass Therapeutics 15-Oct-2026 Drug Discovery Clinical Trials - Phase 1
Marea 17-Sep-2026 Biotechnology Clinical Trials - Phase 2
Sling Therapeutics 16-Sep-2026 Drug Discovery Clinical Trials - Phase 3
CaMaRa 09-Sep-2026 Drug Discovery Startup
Solstice Oncology 09-Sep-2026 Biotechnology Clinical Trials - Phase 2
Korsana Biosciences 07-Sep-2026 Drug Discovery Pre-Clinical Trials
Kynexis 19-Aug-2026 Drug Discovery Clinical Trials - Phase 2
Slate Medicines 17-Aug-2026 PIPE Biotechnology Clinical Trials - Phase 1
Expedition Therapeutics 05-Aug-2026 Early Stage VC Biotechnology Clinical Trials - Phase 2
You’re viewing 10 of 256 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forbion Exits (109)

Company Name Exit Date Exit Type Exit Size
AM-Pharma 20-Oct-2026 Merger/Acquisition
Marea 17-Sep-2026
Braveheart Bio 06-Aug-2026
Crescent Biopharma 16-Jul-2026
Damora Therapeutics ( Drug Discovery) 10-Feb-2026
Precirix 20-Jan-2026
Rampart Bioscience 09-Jan-2026
Dualyx 17-Nov-2025
EnGene Therapeutics 14-Nov-2025 Public Investment 2nd Offering
Vor Biopharma 12-Nov-2025 Public Investment 2nd Offering
You’re viewing 10 of 109 exits. Get the full list »

Forbion Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Forbion‘s full profile, request access.

Request a free trial

Forbion Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Forbion FAQs

  • What is Forbion?

    Founded in 2000, Forbion is a venture capital firm based in Naarden, Netherlands.

  • When was Forbion founded?

    Forbion was founded in 2000.

  • Where is Forbion headquartered?

    Forbion is headquartered in Naarden, Netherlands.

  • What is Forbion's total asset value?

    Forbion has around in total assets under management.

  • How many investments has Forbion made?

    Forbion has made 256 investments.

  • What has Forbion invested in?

    Forbion has made numerous investments in companies like VectorY Therapeutics, OMass Therapeutics, and Marea within the Drug Discovery and Biotechnology industries.

  • What has Forbion invested in recently?

    Forbion's latest investment was on 11-Nov-2026 in VectorY Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process